New hope for stiff, painful backs: major trial tests promising drug
NCT ID NCT07349329
Summary
This study aims to see if an experimental drug called '608' is better than a placebo at reducing pain and stiffness in people with a specific type of inflammatory back arthritis (non-radiographic axial spondyloarthritis). About 380 adult patients with active symptoms and signs of inflammation will be randomly assigned to receive either the drug or a placebo. The main goal is to measure how many people experience significant improvement in pain, function, and stiffness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AXIAL SPONDYLOARTHRITIS, NON-RADIOGRAPHIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Site 01
Beijing, 100730, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.